Guidant On Cloud Nine...

Six weeks ago, I was patting myself on the back saying how $10 profit for 3 weeks on the Guidant deal isn't that bad. Well, it's $12 more since then (coming to around $80 in total), and this is higher than any price any GDT shareholder has ever gotten out of any acquiror, even before all the controversies hit the newswire. It's a stupid price and Boston Scientific is looking desperate, to say the least. GDT should hit that bid and make their shareholders happier than ever.